OQS
TXG icon

Occudo Quantitative Strategies’s 10x Genomics TXG Stock Holding History

Occudo Quantitative Strategies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,774
Closed -$905K – 1388
2022
Q3 		$905K Buy
+31,774
New +$1.21M 0.07% 441
2021
Q1 		– Sell
-2,327
Closed -$330K – 928
2020
Q4 		$330K Buy
+2,327
New +$338K 0.1% 382

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Occudo Quantitative Strategies's TXG Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of 10x Genomics (TXG) in Q4 2022, closing a stake of 31,774 shares — an estimated $905K sold.

Occudo Quantitative Strategies first reported a position in TXG in Q4 2020 and held it in 2 quarters. The position peaked at $905K in Q3 2022. 268 funds tracked by Wall St. Rank hold TXG as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining 10x Genomics position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 31,774 10x Genomics shares in Q4 2022, an estimated $905K.
  • Occudo Quantitative Strategies first reported a position in 10x Genomics in Q4 2020 and held it in 2 quarters.
  • Occudo Quantitative Strategies's 10x Genomics position peaked at $905K in Q3 2022.
  • 268 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.